Biomason is a developer of a building materials technology that employs natural microorganisms to grow bio cement in ambient temperatures.
Biomason has raised $36.7M in total funding. The most recent round was Undisclosed. The last funding was announced in January 2025.
Biomason's investors include 2150, National Science Foundation, Novo Holdings, Hartree Partners, Martin Marietta.
Biomason is headquartered in Durham, United States.
Biomason is a developer of a building materials technology that employs natural microorganisms to grow bio cement in ambient temperatures.
Biomason is at the Undisclosed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Biomason — Funding & Investors." VCBacked, January 2, 2025, https://www.vcbacked.co/company/biomason. Accessed August 15, 2026.
VCBacked. (2025). Biomason — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/biomason
{{cite web |title=Biomason — Funding & Investors |url=https://www.vcbacked.co/company/biomason |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated